On June 29, 2023, STEMCELL Technologies' Dr. Andrew Gaffney and Dr. Erin Knock presented on how to streamline PSC-related workflows using highly characterized induced pluripotent stem cells (iPSCs) and neural progenitor cells (NPCs), and how to differentiate these cells into a variety of cell types downstream. In this Q&A report, you can read their answers to questions asked by the audience. Answers have been edited for length and/or clarity.
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.
Marta Walasek and Danielle Nguyen Truong provide tips and tricks to lock down effective genome editing conditions for CD34+ cells, methods to evaluate genome editing efficiency, and optimal culture conditions to maintain Hematopoeitic stem cell function and long-term editing effects.
Experts provide tips and tricks to lock down effective genome editing conditions for CD34+ cells, methods to evaluate genome editing efficiency, and optimal culture conditions to maintain HSPC function and long-term editing effects.
Dr. Rafael Carazo Salas describes the use of multicolour, multiday high-content microscopy to visualise the dynamic cell fate changes of human pluripotent stem cells collectively and at single-cell level.